ATHA Competitors & Alternatives
Compare Athira Pharma Inc with similar stocks in the same industry
Biotechnology
ATHA
Main Stock$6.75
Tradestie Score
56
Market Cap
$16.56M
Analyst Upside
-40.7%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.99
|
$154.27M | - | 55 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.29
|
$153.02M | - | 56 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.82
|
$133.50M | - | 62 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.03
|
$114.01M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.64
|
$110.20M | - | 60 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.60
|
$97.42M | - | 57 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$4.91
|
$85.47M | - | 62 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$29.99
|
$76.55M | - | 61 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.51
|
$71.69M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$11.09
|
$67.94M | - | 62 | Compare |
More ATHA Analysis
Data updated: Jul 09, 2026 | Industry: Biotechnology (SIC 2836)
238 stocks in this industry